Literature DB >> 10694982

Human in vitro immune responses to Mycobacterium tuberculosis.

M L Wilsher1, C Hagan, R Prestidge, A U Wells, G Murison.   

Abstract

SETTING: T helper cells can be divided into 2 subsets on the basis of their cytokine generation. T helper 1 cells secreting gamma interferon and interleukin 2 appear to be more prominent in patients with limited tuberculous disease.
OBJECTIVE: The purpose of this study was to evaluate human T helper cell immune responses to mycobacterial antigens in vitro and correlate these with the clinical features of patients with tuberculous infection or disease.
DESIGN: We studied 51 subjects and 11 controls who were grouped according to disease involvement as follows: 1) Mantoux negative, BCG negative, no disease; 2) Mantoux positive, no disease; 3) localized extrapulmonary; 4) healed pulmonary; 5) active pulmonary; and 6) miliary/disseminated. Peripheral blood mononuclear cells were cultured with PHA, PPD or Tetanus Toxoid, proliferation assessed and the supernatant analysed using an ELISA for IFN gamma. ELISA was also used to measure M. tuberculosis specific antibodies in the serum.
RESULTS: Mantoux size correlated with PPD proliferation r = 0.5, P = 0.005 and gamma IFN production r = 0.36, P < 0.01. All groups produced abundant gamma IFN although there was a trend toward higher production in groups 3 and 4. M. tuberculosis specific IgA (P = 0.003) and IgG1 (P = 0.002) was higher in groups 5 and 6. Those patients with limited disease (groups 2-4) had significantly lower levels of IgG4 than patients with severe disease (groups 5 &amp; 6) (P < 0.02).
CONCLUSION: In conclusion patients with healed or extrapulmonary disease have immune responses in vitro suggestive of a TH1 (cell mediated immune) response, whereas patients with miliary/disseminated disease have antibody production suggestive of a TH2 response, together with high gamma IFN production. Both TH1 and TH2 responses may be necessary for host protection if there is a high bacillary load.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10694982     DOI: 10.1054/tuld.1999.0223

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  22 in total

Review 1.  Unfolding the relationship between secreted molecular chaperones and macrophage activation states.

Authors:  Brian Henderson; Samantha Henderson
Journal:  Cell Stress Chaperones       Date:  2008-10-29       Impact factor: 3.667

2.  Down-regulation of interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes by interleukin-4 and -10 but not by interleukin-13.

Authors:  C Ameixa; J S Friedland
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis.

Authors:  Suraj B Sable; Rajnish Kumar; Mamta Kalra; Indu Verma; G K Khuller; Karen Dobos; John T Belisle
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Assessment of the IgA immunoassay diagnostic potential of the Mycobacterium tuberculosis MT10.3-MPT64 fusion protein in tuberculous pleural fluid.

Authors:  Leonardo Silva Araujo; Renata de Moraes Maciel; Renata Maciel Moraes; Anete Trajman; Maria Helena Féres Saad
Journal:  Clin Vaccine Immunol       Date:  2010-10-20

5.  A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.

Authors:  M A Skinner; A J Ramsay; G S Buchan; D L Keen; C Ranasinghe; L Slobbe; D M Collins; G W de Lisle; B M Buddle
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

6.  Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis.

Authors:  Christina T Fiske; Alexandre S de Almeida; Ayumi K Shintani; Spyros A Kalams; Timothy R Sterling
Journal:  Clin Vaccine Immunol       Date:  2012-06-06

7.  Immunoglobulin G subisotype responses of pneumonic and healthy, exposed foals and adult horses to Rhodococcus equi virulence-associated proteins.

Authors:  Kathleen E Hooper-McGrevy; Bruce N Wilkie; John F Prescott
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

8.  A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

Authors:  Margot A Skinner; Bryce M Buddle; D Neil Wedlock; Denise Keen; Geoffrey W de Lisle; Ricardo E Tascon; Jose Candido Ferraz; Douglas B Lowrie; Paul J Cockle; H Martin Vordermeier; R Glyn Hewinson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Cell-mediated immune responses of healthy laboratory volunteers to sonicate antigens prepared from the most prevalent strains of Mycobacterium tuberculosis from South India harboring a single copy of IS6110.

Authors:  Priya Rajavelu; Sulochana D Das
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

Review 10.  Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps.

Authors:  Jyoti S Mathad; Amita Gupta
Journal:  Clin Infect Dis       Date:  2012-08-31       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.